Hyperhomocysteinemia and elevated ox-LDL in Tunisian type 2 diabetic patients: role of genetic and dietary factors

Clin Biochem. 2007 Sep;40(13-14):1007-14. doi: 10.1016/j.clinbiochem.2007.05.017. Epub 2007 Jun 14.

Abstract

Introduction: Total plasma homocysteine (tHcy) is an emerging risk factor for the development of atherosclerosis. However, its relationship with diabetes is still unclear.

Objectives: We evaluated the association between tHcy levels and methylenetetrahydrofolate reductase (MTHFR) 677C-->T genotype in a type 2 diabetes mellitus (DM) population and their relationship with oxidized LDL (ox-LDL) according to dietary habits and vascular complications.

Design and methods: Eighty-six DM patients were compared to 120 healthy volunteers.

Results: Associated higher tHcy levels and significantly higher ox-LDL levels (p<0.001) were found in DM patients compared to healthy subjects. Homozygosity for the T allele of MTHFR was more frequent in diabetics than in healthy subjects (12.8% vs. 7.2%) and it was associated with higher tHcy levels. Moreover, this elevated level was associated with significantly higher ox-LDL levels in DM patients with hypertension (p<0.05). Improving folate and vitamin C intakes could have beneficial effects on lowering the tHcy and ox-LDL levels.

Conclusions: The interplay of genetic and dietary factors modulates the effect of homocysteine on cardiovascular risk factors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Case-Control Studies
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / genetics
  • Female
  • Homocystine / blood
  • Humans
  • Hyperhomocysteinemia / blood*
  • Lipoproteins, LDL / blood*
  • Male
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics
  • Middle Aged
  • Multivariate Analysis
  • Polymorphism, Genetic
  • Risk Factors
  • Tunisia

Substances

  • Lipoproteins, LDL
  • oxidized low density lipoprotein
  • Homocystine
  • Methylenetetrahydrofolate Reductase (NADPH2)